Treatment of QÅ«bÄ- (Dermatophytosis) by Unani medicine - Habbe Kibreet Sagheer

Phase 2

Not yet recruiting

Brief Summary: Participants attending the GOPD of National Research Institute of Unani Medicine for Skin Disorders, Hyderabad will be evaluated for presence of *QÅ«bÄ*. The participants will be assessed for clinical and laboratory parameters. If, they do not meet the exclusion criteria and fulfil the inclusion criteria, they will be enrolled in the present study. They will be informed about the nature and objectives of the study, and details of other study related procedures. Written and signed informed consent form will be obtained from the participants before enrolling them into the study. A detailed clinical history will be recorded and complete physical examination will be carried out to record the various signs and symptoms of *QÅ«bÄ*. Blood samples will be collected for pathological and biochemical investigations. Study drug will be dispensed as per schedule and participants will be instructed to take the medicine as per the protocol. i.e. *Habbe Kibreet Sagheer- one pill of 250 mg to be taken twice daily orally with water for 4 weeks.*

Recruitment & Eligibility

Inclusion Criteria

QÅ«bÄ (Dermatophytosis) of < 2 weeks duration 2.
Patients with KOH positive 3.
lesions having any of the following symptoms: Presence of pruritus and burning, Presence of scales, Presence of central clearing, Erythematous papules.

Exclusion Criteria

1.Co-morbid conditions of the participants 2.Pregnant or Lactating Women 3.Significant Pulmonary/Cardiovascular/Hepato-renal Dysfunction 4.Known cases of Immuno-compromised states (HIV/ AIDS, etc.) Malignancies â€¢Participants not willing to attend treatment schedule regularly 5.History of hypersensitivity to clotrimazole 6.Participants using the following medications: 7.Systemic antifungal within 15 days of baseline visit.
8.Systemic corticosteroids within 15 days of baseline visit.

Primary Outcome Measures

Name	Time	Method
To assess the safety of Unani Pharmacopoeial formulation Habbe-kibreet Sagheer in cases of QÅ«bÄ (Dermatophytosis).	1st week , 4th week

Secondary Outcome Measures

Name	Time	Method
â€¢To assess the efficacy of Unani Pharmacopoeial formulation Habbe-kibreet Sagheer in cases of QÅ«bÄ (Dermatophytosis).	1st, 2nd, 3rd, 4th week

Locations (1): National Research Institute of Unani Medicine for Skin Disorders
🇮🇳
Hyderabad, TELANGANA, India
National Research Institute of Unani Medicine for Skin Disorders
🇮🇳Hyderabad, TELANGANA, India
DR SYED GULNAWAZ AHMED
Principal investigator
9848716693
skgulnawaz@gmail.com